Oyster Point Pharma

Oyster Point Pharma

World Rank (Jan-05-2024)
15,755
World Rank (Jul-30-2023)
15,755
Market Cap (Jul-30-2023)
0.303 Billion USD
World Rank (Jan-07-2022)
14,658
Market Cap (Jan-07-2022)
0.419 Billion USD
World Rank (Jan-01-2021)
11,274
Market Cap (Jan-01-2021)
0.487 Billion USD
Headquarters Country
USA
Headquarters City/State
New Jersey
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
0 Million USD
Annual Net Income in USD
-71 Million USD
Annual Results for Period Ending
Dec-2020 ending year
Balance Sheet for Period Ending
Dec-2020 ending year
Business Sector
Healthcare
Biotechnology
Biopharmaceutical
Company Website
OYSTER POINT PHARMA
Company Profile

Oyster Point Pharma is a Clinical Stage Biopharmaceutical company focused on the discovery, development and commercialization of first in class pharmaceutical therapies to treat ocular surface diseases. The company annual revenue is 16.5 million USD and 62 employees as on 2020. The headquarters is in USA.

Founded Year
2015
Stock Exchange
Nasdaq

Share